Let's assume that the results are as good in phase 3 as they are in phase 2, in which case, then we'll have something to offer our patients, rather than just fewer injections, we should be able to offer them, hopefully, better acuity.
https://www.modernretina.com/view/euretina-2024-new-therapeutics-for-wet-amd-address-the-broader-vegf-family
Let's assume that the results are as good in phase 3 as they are...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.5¢ |
Change
0.030(3.82%) |
Mkt cap ! $1.003B | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 82.5¢ | 78.5¢ | $1.203M | 1.499M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5772 | 81.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.5¢ | 844 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |